chr2-27381615-T-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_177983.3(PPM1G):āc.1625A>Cā(p.Lys542Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000601 in 1,611,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K542E) has been classified as Likely benign.
Frequency
Consequence
NM_177983.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000665 AC: 101AN: 151934Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000509 AC: 128AN: 251488Hom.: 0 AF XY: 0.000537 AC XY: 73AN XY: 135918
GnomAD4 exome AF: 0.000595 AC: 868AN: 1459780Hom.: 0 Cov.: 31 AF XY: 0.000602 AC XY: 437AN XY: 726204
GnomAD4 genome AF: 0.000665 AC: 101AN: 151934Hom.: 0 Cov.: 32 AF XY: 0.000674 AC XY: 50AN XY: 74222
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.1625A>C (p.K542T) alteration is located in exon 10 (coding exon 10) of the PPM1G gene. This alteration results from a A to C substitution at nucleotide position 1625, causing the lysine (K) at amino acid position 542 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at